COAGULANT THERAPEUTICS CORP has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Australia and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are QUINTESSENCE BIOSCIENCES INC, OXTHERA INTELLECTUAL PROPERTY AB and ORPRO THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 2 | |
#3 | Israel | 2 | |
#4 | United States | 2 | |
#5 | New Zealand | 1 | |
#6 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Enzymes | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Bauzon Maxine | 9 |
#2 | Hermiston Terry | 9 |
#3 | Feldman Richard Ira | 1 |
Publication | Filing date | Title |
---|---|---|
AU2013370522A1 | Short-acting Factor VII polypeptides |